Wild-type p53 controls the level of fibronectin expression in breast cancer cells
Daeun You(Samsung (South Korea)), Sangmin Kim(Ulsan College)
Cited by 9
Related Papers
Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway
|Oncotarget|2015|46
Celastrol attenuates the inflammatory response by inhibiting IL‑1β expression in triple‑negative breast cancer cells
|Oncology Reports|2021|38
Induction of fibronectin in response to epidermal growth factor is suppressed by silibinin through the inhibition of STAT3 in triple negative breast cancer cells
|Oncology Reports|2014|30
Fibronectin expression is upregulated by PI-3K/Akt activation in tamoxifen-resistant breast cancer cells
|BMB Reports|2017|27
Tumorigenicity of EGFR- and/or HER2-Positive Breast Cancers Is Mediated by Recruitment of Tumor-Associated Macrophages
|International Journal of Molecular Sciences|2023|10